| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 1 | 降低胆固醇的酵素原液及其制备方法 | CN201510571339.1 | 2015-09-09 | CN105146517A | 2015-12-16 | 董轲 |
| 一种降低胆固醇的酵素原液，其特征在于，由以下质量百分比的组分制成：果蔬21％、红糖5％、益生菌群0.1％、调味料5％、氯化钠0.2％、富硒酵母0.1％、香椿素2％、百合提取物0.2％、绞股蓝提取物0.2％、芝麻叶提取物0.2％、党参提取物0.2％、白芷提取物0.2％、西洋参提取物0.2％、丝瓜络提取物0.2％、薄荷叶提取物0.2％、余量为纯净水；本发明配方简单，各组分之间搭配合理，营养互补，制备出来的饮料色泽自然，无异味，口感好，长喝能够起到降低胆固醇的功效。 | ||||||
| 2 | 具有提高免疫力的猪用饲料添加剂 | CN201511010918.5 | 2015-12-30 | CN105454661A | 2016-04-06 | 朱长生; 赵艳平; 李世传 |
| 本发明涉及一种具有提高免疫力的猪用饲料添加剂，属于饲料添加剂领域。该饲料添加剂由以下原料组成：川芎，地骨皮，杜仲，牛蒡子，红景天，植物多糖，有益菌菌粉。本发明能有效提高乳猪的免疫功能，从根本上提高乳猪的抗病能力，减少抗生素和药物的使用，促进乳猪的生长，提高养殖经济效益。同时，本发明所使用的原料均为无毒无害无残留的绿色添加剂，具有安全环保的特点，可广泛应用与乳猪日粮。 | ||||||
| 3 | 抗衰老胶原蛋白肽粉 | CN201610386964.3 | 2016-06-02 | CN105996056A | 2016-10-12 | 王斐芬 |
| 本发明公开了一种抗衰老胶原蛋白肽粉，由下述重量份的原料组成：胶原蛋白肽粉58‑62份、蔗果三糖2‑8份、酪蛋白水解肽8‑12份、枸杞12‑18份、复合酵素8‑12份、壳六糖1‑5份、保鲜剂0.01‑1份。本发明具有强化体质耐力、改善胃肠道功能、美容养颜、抗衰老的作用。 | ||||||
| 4 | 一种抗衰老海藻保健藻粒饮料及其制备方法 | CN201510851043.5 | 2015-11-30 | CN105475761A | 2016-04-13 | 赵超; 刘斌; 艾超; 肖正 |
| 本发明属于保健饮料的制备领域，具体涉及一种抗衰老海藻保健藻粒饮料及其制备方法。所述的饮料以海藻营养液为主，组分按干重质量比计包括：竹荪4-5份、茶树菇4-5份、麒麟菜8-10份、紫菜6-8份、海发菜3-5份、南极冰藻2-4份、蜈蚣藻2-4份、羊栖菜1-2份、裙带菜1-2份、小球藻0.5-1份。本发明运用了一整套的连续式生产工艺，经水提取法、好氧发酵、厌氧发酵、除杂等步骤，可将海藻中的生物活性提取物生产成为一种抗衰老饮料。整个生产线，产量高、零排放，比以往的单一提取法产量高出数倍。该生产工艺不仅将海藻的利用价值最大化，而且工艺简单，耗能低，有效实现零排放、无污染的工业生产。 | ||||||
| 5 | Compositions for the vaginal and oral administration of Lactobacillus and uses thereof | US13821431 | 2011-09-13 | US08846027B2 | 2014-09-30 | Herbert Kiss; Konrad J. Domig; Wolfgang Kneifel; Helmut Viernstein; Frank M. Unger |
| The present invention relates to compositions for the oral and vaginal administration of human Lactobacilli and uses thereof for physiologic restoration of the vaginal flora, physiologic maintenance of Lactobacillus flora in pathologic deficiency to produce Lactobacilli, treatment of asymptomatic bacterial vaginosis and prevention of preterm delivery caused through bacterial vaginosis. | ||||||
| 6 | LACTOBACILLUS SP. STRAIN HAVING ABILITY TO INHIBIT PROLIFERATION OF VIRGINAL PATHOGENIC MICROORGANISMS | US15566352 | 2016-03-24 | US20180117100A1 | 2018-05-03 | Gwang Pyo KO; Hyun Ju YOU; Bo Mi KWON |
| The present invention relates to a novel Lactobacillus sp. isolation strain having an activity to inhibit the growth of vaginitis pathogens, and a pharmaceutical composition, a health functional food, and a cleansing product, comprising the strain as an active ingredient. Therefore, the present invention exhibits an effect of inhibiting the growth of Sneathia spp. pathogens associated with the infection with human papillomavirus (HPV) and the incidence of bacterial vaginitis, Gardnerella vaginalis as a vaginitis pathogen, and Candida albicans as a causative bacteria of Candidal vaginitis, and an effect of recovering and maintaining the vaginal microflora, and thus can be used for the prevention and treatment of female vaginitis. | ||||||
| 7 | COMPOSITIONS FOR THE VAGINAL AND ORAL ADMINISTRATION OF LACTOBACILLUS AND USES THEREOF | US13821431 | 2011-09-13 | US20130171253A1 | 2013-07-04 | Herbert Kiss; Konrad J. Domig; Wolfgang Kneifel; Helmut Viernstein; Frank M. Unger |
| The present invention relates to compositions for the oral and vaginal administration of human Lactobacilli and uses thereof for physiologic restoration of the vaginal flora, physiologic maintenance of Lactobacillus flora in pathologic deficiency to produce Lactobacilli, treatment of asymptomatic bacterial vaginosis and prevention of preterm delivery caused through bacterial vaginosis. | ||||||
| 8 | COMPOSITIONS FOR THE VAGINAL AND ORAL ADMINISTRATION OF LACTOBACILLUS AND USES THEREOF | EP11767944.9 | 2011-09-13 | EP2509610B1 | 2013-03-27 | KISS, Herbert; UNGER, Frank.M.; DOMIG, Konrad, J.; VIERNSTEIN, Helmut.; KNEIFEL, Wolfgang. |
| The present invention relates to compositions for the oral and vaginal administration of human Lactobacilli and uses thereof for physiologic restoration of the vaginal flora, physiologic maintenance of Lactobacillus flora in pathologic deficiency to produce Lactobacilli, treatment of asymptomatic bacterial vaginosis and prevention of preterm delivery caused through bacterial vaginosis. | ||||||
| 9 | COMPOSITIONS FOR THE VAGINAL AND ORAL ADMINISTRATION OF LACTOBACILLUS AND USES THEREOF | EP11767944.9 | 2011-09-13 | EP2509610A1 | 2012-10-17 | KISS, Herbert; UNGER, Frank.M.; DOMIG, Konrad, J.; VIERNSTEIN, Helmut.; KNEIFEL, Wolfgang. |
| The present invention relates to compositions for the oral and vaginal administration of human Lactobacilli and uses thereof for physiologic restoration of the vaginal flora, physiologic maintenance of Lactobacillus flora in pathologic deficiency to produce Lactobacilli, treatment of asymptomatic bacterial vaginosis and prevention of preterm delivery caused through bacterial vaginosis. | ||||||
| 10 | Compositions for the vaginal and oral administration of lactobacillus and uses thereof | EP10176578.2 | 2010-09-14 | EP2428214A1 | 2012-03-14 | Kiss, Herbert |
The present invention relates to compositions for the oral and vaginal administration of human Lactobacilli and uses thereof for physiologic restoration of the vaginal flora, physiologic maintenance of Lactobacillus flora in pathologic deficiency to produce Lactobacilli, treatment of asymptomatic bacterial vaginosis and prevention of preterm delivery caused through bacterial vaginosis. |
||||||
| 11 | 질 내 병원성 미생물에 대한 증식억제활성을 갖는 락토바실러스 속 균주 | KR1020170041922 | 2017-03-31 | KR101867048B1 | 2018-06-12 | 고광표; 유현주; 권보미 |
| 본발명은질염병원균증식억제활성을지닌신규의락토바실러스속 분리균주, 및이를유효성분으로함유하는약학적조성물, 건강기능식품, 및세정제품에관한것이다. 따라서, 본발명은인유두종바이러스(HPV) 감염및 세균성질염의발병과관련된스니치아속(spp.) 병원균, 질염병원균인가드네렐라바지날리스(), 칸디다성질염의원인균인칸디다알비칸스()에대한증식억제효과및 질내 균총의회복과유지효과를나타내어여성질염의예방과치료에사용될수 있다. | ||||||
| 12 | 질 내 병원성 미생물에 대한 증식억제활성을 갖는 락토바실러스 속 균주 | KR1020160022840 | 2016-02-25 | KR101860552B1 | 2018-07-02 | 고광표; 유현주; 권보미 |
| 본발명은질염병원균증식억제활성을지닌신규의락토바실러스속 분리균주, 및이를유효성분으로함유하는약학적조성물, 건강기능식품, 및세정제품에관한것이다. 따라서, 본발명은인유두종바이러스(HPV) 감염및 세균성질염의발병과관련된스니치아속(spp.) 병원균, 질염병원균인가드네렐라바지날리스(), 칸디다성질염의원인균인칸디다알비칸스()에대한증식억제효과및 질내 균총의회복과유지효과를나타내어여성질염의예방과치료에사용될수 있다. | ||||||
| 13 | 질 내 병원성 미생물에 대한 증식억제활성을 갖는 락토바실러스 속 균주 | KR1020180003582 | 2018-01-10 | KR101860553B1 | 2018-05-23 | 고광표; 유현주; 권보미 |
| 본발명은질염병원균증식억제활성을지닌신규의락토바실러스속 분리균주, 및이를유효성분으로함유하는약학적조성물, 건강기능식품, 및세정제품에관한것이다. 따라서, 본발명은인유두종바이러스(HPV) 감염및 세균성질염의발병과관련된스니치아속(spp.) 병원균, 질염병원균인가드네렐라바지날리스(), 칸디다성질염의원인균인칸디다알비칸스()에대한증식억제효과및 질내 균총의회복과유지효과를나타내어여성질염의예방과치료에사용될수 있다. | ||||||
| 14 | 질 내 병원성 미생물에 대한 증식억제활성을 갖는 락토바실러스 속 균주 | KR1020180003582 | 2018-01-10 | KR1020180006998A | 2018-01-19 | 고광표; 유현주; 권보미 |
| 본발명은질염병원균증식억제활성을지닌신규의락토바실러스속 분리균주, 및이를유효성분으로함유하는약학적조성물, 건강기능식품, 및세정제품에관한것이다. 따라서, 본발명은인유두종바이러스(HPV) 감염및 세균성질염의발병과관련된스니치아속(spp.) 병원균, 질염병원균인가드네렐라바지날리스(), 칸디다성질염의원인균인칸디다알비칸스()에대한증식억제효과및 질내 균총의회복과유지효과를나타내어여성질염의예방과치료에사용될수 있다. | ||||||
QQ群二维码
意见反馈
意见反馈